An anti-inflammatory agent
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Actarit

Item No. 20852

Technical Information
Formal Name
4-(acetylamino)-benzeneacetic acid
CAS Number
18699-02-0
Synonyms
  • 4-Acetylaminophenylacetic Acid
  • MS-932
  • NSC 170317
Molecular Formula
C10H11NO3
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 20 mg/mlDMSO: 20 mg/mlDMSO:PBS (pH 7.2)(1:9): 0.1 mg/mlEthanol: 3 mg/ml
λmax
246 nm
SMILES
CC(NC1=CC=C(CC(O)=O)C=C1)=O
InChi Code
InChI=1S/C10H11NO3/c1-7(12)11-9-4-2-8(3-5-9)6-10(13)14/h2-5H,6H2,1H3,(H,11,12)(H,13,14)
InChi Key
MROJXXOCABQVEF-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Actarit is an anti-inflammatory agent.1,2 It inhibits carbonic anhydrase II (CAII; IC50 = 422 nM).3 Actarit decreases disease severity in a mouse model of arthritis induced by type II collagen, as well as in a rat model of experimental autoimmune encephalomyelitis (EAE).1,2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Fujisawa, H., Nishimura, T., Motonaga, A., et alEffect of actarit on type II collagen-induced arthritis in mice. Arznei.-Forschung 44(1), 64-68 (1994).

    2. Kawai, K., Kobayashi, Y., Hirayama, M., et alSuppressive effects of 4-acetylaminophenylacetic acid (actarit) on experimental autoimmune encephalomyelitis in rats. Immunopharmacol. 39(2), 127-138 (1998).

    3. Ghislat, G., Rahman, T., and Ballester, P.J. Identification and validation of carbonic anhydrase II as the first target of the anti-inflammatory drug actarit. Biomolecules 10(11), 1570 (2020).